Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

Published:2008-07 Issue:1 Volume:38 Page:837-844
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Cudkowicz Merit E.,Shefner Jeremy M.,Simpson Elizabeth,Grasso Daniela,Yu Hong,Zhang Hui,Shui Amy,Schoenfeld David,Brown Robert H.,Wieland Scott,Barber Jack R.,

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Reference27 articles.

1. A controlled trial of Riluzole in amyotrophic lateral sclerosis;Bensimon;N Engl J Med,1994

2. Up‐regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn‐superoxide dismutase mutants associated with amyotrophic lateral sclerosis;Bruening;J Neurochem,1999

3. Aggregation and motor neuron toxicity of an ALS‐linked SOD1 mutant independent from wild‐type SOD1;Bruijn;Science,1998

4. TDP‐43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions;Cairns;Am J Pathol,2007

5. Trial of Celecoxib in Amyotrophic Lateral Sclerosis;Cudkowicz;Ann Neurol,2006

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis;Heliyon;2024-08

2. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial;The Lancet Neurology;2024-07

3. Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis;2024-06-01

4. Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy;Current Opinion in Neurology;2023-08-30

5. Therapeutic targeting ofALSpathways: Refocusing an incomplete picture;Annals of Clinical and Translational Neurology;2023-08-28